About Injective
Injective is a company based in New York (United States) founded in 2018 by Albert Chon and Eric Chen. It operates as a Blockchain-as-a-Service and Token / Crypto Economy. Injective has raised $95.2 million across 5 funding rounds from investors including BlockTower, QCP Capital and Jump Crypto. Injective offers products and services including Injective Blockchain, Injective Wallet, and INJ Token. Injective operates in a competitive market with competitors including Consensys, Luno, Ripple, Amber Group and Matrixport, among others.
- Headquarter New York, United States
- Founders Albert Chon, Eric Chen
-
Sectors
TechnologyFinancial Services
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Injective Foundation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$95.2 M (USD)
in 5 rounds
-
Latest Funding Round
$40 M (USD), Series B
Aug 15, 2022
-
Investors
BlockTower
& 16 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Injective
Injective offers a comprehensive portfolio of products and services, including Injective Blockchain, Injective Wallet, and INJ Token.
A blockchain platform is provided for financial applications.
A wallet service is offered for asset management.
Native utility token is used within the ecosystem.
People of Injective
Unlock access to complete
Funding Insights of Injective
Injective has successfully raised a total of $95.2M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $40 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Injective
Injective has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include BlockTower, QCP Capital and Jump Crypto.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Blockchain-focused investment funds and venture capital are provided.
|
Locked | Locked | Locked | |
|
Cryptocurrency and digital asset investments are managed by the firm.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on crypto-assets
|
Locked | Locked | Locked |
Investor details for Injective
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Injective
Investment portfolio details for Injective
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Injective
Detailed financials for Injective
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Injective Comparisons
Peer comparison for Injective
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Injective
Injective operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Consensys, Luno, Ripple, Amber Group and Matrixport, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of blockchain and web3 software platform
|
|
| Locked | Locked | Locked |
Mobile app for storing and trading cryptocurrencies is utilized.
|
|
| Locked | Locked | Locked |
Blockchain-based payment network for cross-border transfers is developed.
|
|
| Locked | Locked | Locked |
Blockchain-based financial solutions are offered for crypto trading and payments.
|
|
| Locked | Locked | Locked |
App-based platform offering crypto investment products and financial services solutions
|
|
| Locked | Locked | Locked |
An app-based platform is offered for cryptocurrency trading and investments.
|
Detailed competitors of Injective
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Injective
Complete news archive for Injective
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Injective
Injective was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Injective is headquartered in New York, United States. It is registered at New York, New York, United States.
Injective is a funded company, having raised a total of $95.2M across 5 funding rounds to date.
A specialized blockchain is built by Injective for finance and Web3 innovation. Financial applications are supported through plug-and-play modules that simplify development. Technical complexities are abstracted to enable hyper-performant applications with minimal barriers. The ecosystem is recognized as one of the largest and fastest-growing in Web3 finance, connecting various dApps, chains, and institutions. Solutions like asset bridging and staking are provided to enhance user engagement in decentralized finance.
Injective offers Injective Blockchain, Injective Wallet, and INJ Token.
Injective has 17 investors. Key investors include BlockTower, QCP Capital, Jump Crypto, Brevan Howard, and Pantera Capital.